App
Moneycontrol App Android App iOS App iPad App Android Tab Blackberry Windows App Windows Tab
Subscription
Specials
Stocks
Feedback
Log In
Sign Up
Moneycntrol
Co-Partners
Associate Partners
Get App
Select Language
Subscription
Specials
Moneycontrol

Co-Partners

Medlife
Mobil

Associate Partners

Close Ad
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Profit & Loss account - Dr Reddys Laboratories

Dr Reddys Laboratories

BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 20, 10:15
2621.20
-126.9 (-4.62%)
VOLUME 20,545
LIVE
NSE
May 20, 10:16
2621.55
-123.45 (-4.5%)
VOLUME 620,575
Download Annual Report PDF Format 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010
Previous Years

Profit & Loss account of Dr Reddys Laboratories

 ------------------- in Rs. Cr. -------------------
Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
12 mths 12 mths 12 mths 12 mths 12 mths
INCOME
Revenue From Operations [Gross] 10,466.70 9,302.60 9,628.10 10,234.80 10,010.40
Less: Excise/Sevice Tax/Other Levies 0.00 0.00 0.00 84.20 82.90
Revenue From Operations [Net] 10,466.70 9,302.60 9,628.10 10,150.60 9,927.50
Other Operating Revenues 158.80 56.70 91.70 57.10 83.50
Total Operating Revenues 10,625.50 9,359.30 9,719.80 10,207.70 10,011.00
Other Income 238.40 204.00 591.20 244.80 222.80
Total Revenue 10,863.90 9,563.30 10,311.00 10,452.50 10,233.80
EXPENSES
Cost Of Materials Consumed 2,103.20 2,011.00 1,904.60 1,988.50 2,248.40
Purchase Of Stock-In Trade 868.60 671.60 671.50 610.40 526.10
Operating And Direct Expenses 0.00 0.00 0.00 94.20 92.40
Changes In Inventories Of FG,WIP And Stock-In Trade 66.00 -51.60 1.90 -28.80 -28.90
Employee Benefit Expenses 1,931.90 1,843.00 1,803.30 1,710.00 1,490.90
Finance Costs 56.80 62.80 57.20 63.80 63.80
Depreciation And Amortisation Expenses 780.60 774.10 735.10 649.10 490.20
Other Expenses 3,356.10 3,555.40 3,592.90 3,429.40 3,291.00
Total Expenses 9,163.20 8,866.30 8,766.50 8,516.60 8,173.90
Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
12 mths 12 mths 12 mths 12 mths 12 mths
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 1,700.70 697.00 1,544.50 1,935.90 2,059.90
Exceptional Items 0.00 0.00 0.00 -355.90 0.00
Profit/Loss Before Tax 1,700.70 697.00 1,544.50 1,580.00 2,059.90
Tax Expenses-Continued Operations
Current Tax 423.40 138.10 182.60 416.00 376.70
Less: MAT Credit Entitlement 0.00 0.00 0.00 97.00 0.00
Deferred Tax 0.00 -8.00 -22.20 -93.50 3.80
Total Tax Expenses 423.40 130.10 160.40 225.50 380.50
Profit/Loss After Tax And Before ExtraOrdinary Items 1,277.30 566.90 1,384.10 1,354.50 1,679.40
Profit/Loss From Continuing Operations 1,277.30 566.90 1,384.10 1,354.50 1,679.40
Profit/Loss For The Period 1,277.30 566.90 1,384.10 1,354.50 1,679.40
Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
12 mths 12 mths 12 mths 12 mths 12 mths
OTHER ADDITIONAL INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.) 76.98 34.19 83.05 79.42 99.00
Diluted EPS (Rs.) 76.85 34.12 82.88 79.14 98.00
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS
Imported Raw Materials 0.00 0.00 0.00 766.80 867.70
Indigenous Raw Materials 0.00 0.00 0.00 1,221.70 1,380.70
STORES, SPARES AND LOOSE TOOLS
Imported Stores And Spares 0.00 0.00 0.00 107.00 81.10
Indigenous Stores And Spares 0.00 0.00 0.00 322.10 294.40
DIVIDEND AND DIVIDEND PERCENTAGE
Equity Share Dividend 0.00 399.20 335.30 340.50 340.80
Tax On Dividend 0.00 0.00 0.00 69.30 69.40
Equity Dividend Rate (%) 0.00 400.00 400.00 400.00 400.00
Source : Dion Global Solutions Limited

Results of Dr Reddys Labs

  • News
  • Results
  • Estimates
  • Analysis

Results of Pharmaceuticals Sector

  • News
  • Results
  • Estimates
  • Analysis
No news.
Quick Links for drreddyslaboratories
Related Searches drreddyslaboratories Stock Price, Dr%20Reddys%20Labs Stock Quote, Dr%20Reddys%20Labs Results , Dr%20Reddys%20Labs News .. More »
Follow moneycontrol

Facebook Twitter RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI AndroidWindow

Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Live Sensex | Public Sector Banks | Market Statistics | Plan Insurance | Global Market | Business News | Mutual Fund | Best Portfolio Manager | Bse Sensex | Nse Nifty | Commodities Price | Silver Price/Rate in India | Gold Price/Rate in India | Crude Oil | USD to INR | Bank Fixed Deposits | Company Fixed Deposits | Small Savings Schemes | Bonds | Budget 2019 | Tax Calculator | RBI Credit Policy | News Archive | FAQs | Financial Glossary | Message Board | Moneybhai | Think India | History India | Latest News | IBNLive News | News in Hindi | Cricket News | Online Study Material | India News |Restaurants in Mumbai | Online Shopping in India  | Cairn India | Euro | Infosys | Inflation | Silver | Glenmark Pharmaceuticals | Snapdeal | Starbucks | Narendra Modi | Crore | Clear Study Doubts | Education Franchisee Opportunity | Rss Feeds
Site Map | About Us | Contact Us | Advertise | Bookmark | Disclaimer | Privacy Policy | Terms & Conditions | Careers
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.